Stroke, Vol 23, 1319-1323, Copyright © 1992 by American Heart Association
PG Lysko, TL Yue, JL Gu and G Feuerstein
BACKGROUND AND PURPOSE: The N-methyl-D-aspartate receptor is believed to
mediate part of the ischemic neuronal damage caused by the excitatory amino
acid glutamate. (+)SKF 10,047, the prototypic sigma- agonist, interacts
with the N-methyl-D-aspartate receptor. Therefore, we studied the
neuroprotective effect of (+)SKF 10,047 on cultured rat cerebellar neurons
and on CA1 hippocampal neurons of gerbils exposed to brain ischemia.
METHODS: Mechanisms of neuroprotection were studied in vitro by measuring
calcium influx into cultured rat cerebellar granule cells loaded with fura
2-AM. In vivo neuroprotection of gerbil CA1 hippocampal neurons was studied
in a posttreatment regimen following 5 minutes of bilateral carotid artery
occlusion and 7 days of reperfusion. RESULTS: In primary cultured rat
cerebellar granule cell neurons, (+)SKF 10,047 in a dose-dependent manner
diminished intracellular calcium levels of N-methyl-D-aspartate-stimulated
neurons by a maximum of 87% (n = 8), with a 50% inhibitory concentration of
0.8 microM. (+)SKF 10,047 did not prevent subsequent calcium influx
stimulated by kainic acid or KCl, nor did it interfere with modulation of
the kainate response by quisqualic acid. Neuroprotection of 64% (p = 0.006,
n = 15) of gerbil CA1 hippocampal neurons was achieved by posttreatment
injection followed by minipump infusion. CONCLUSIONS: Neuroprotection by
(+)SKF 10,047 most likely involves interaction at the N-methyl-D-aspartate
receptor. These results suggest that the benzomorphan class of
sigma-agonists may provide neuroprotection in cerebral ischemia and stroke.
ARTICLES
Neuroprotective mechanism of (+)SKF 10,047 in vitro and in gerbil global brain ischemia
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pa. 19406-0939.
This article has been cited by other articles:
![]() |
T. Goyagi, S. Goto, A. Bhardwaj, V. L. Dawson, P. D. Hurn, and J. R. Kirsch Neuroprotective Effect of {{sigma}}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production Stroke, July 1, 2001; 32(7): 1613 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Harukuni, A. Bhardwaj, A. B. Shaivitz, A. C. DeVries, E. D. London, P. D. Hurn, R. J. Traystman, J. R. Kirsch, and F. M. Faraci {sigma}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl)-Piperidine Affords Neuroprotection From Focal Ischemia With Prolonged Reperfusion • Editorial Comment Stroke, April 1, 2000; 31(4): 976 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takahashi, J. R. Kirsch, K. Hashimoto, E. D. London, R. C. Koehler, R. J. Traystman, and P. G. Lysko PPBP [4-Phenyl-1-(4-phenylbutyl) Piperidine] Decreases Brain Injury After Transient Focal Ischemia in Rats Stroke, November 1, 1996; 27(11): 2120 - 2123. [Abstract] [Full Text] |
||||
![]() |
J. Castillo, A. Davalos, J. Naveiro, and M. Noya Neuroexcitatory Amino Acids and Their Relation to Infarct Size and Neurological Deficit in Ischemic Stroke Stroke, June 1, 1996; 27(6): 1060 - 1065. [Abstract] [Full Text] |
||||
![]() |
H. Takahashi, J. R. Kirsch, K. Hashimoto, E. D. London, R. C. Koehler, and R. J. Traystman PPBP [4-Phenyl-1-(4-phenylbutyl) Piperidine], a Potent {varsigma}-Receptor Ligand, Decreases Brain Injury After Transient Focal Ischemia in Cats Stroke, September 1, 1995; 26(9): 1676 - 1682. [Abstract] [Full Text] |
||||
![]() |
F. C. Barone, P. G. Lysko, W. J. Price, G. Feuerstein, K. A. Al-Baracanji, C. D. Benham, D. C. Harrison, M. H. Harries, S. J. Bailey, and A. J. Hunter SB 201823-A Antagonizes Calcium Currents in Central Neurons and Reduces the Effects of Focal Ischemia in Rats and Mice Stroke, September 1, 1995; 26(9): 1683 - 1690. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |